Status:
UNKNOWN
Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
The Ottawa Hospital
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Multiple sclerosis is a neurological disease that can affect lung function and cough efficacy. This pilot study will examine whether the lung volume recruitment technique can slow down the decline in ...
Eligibility Criteria
Inclusion
- History of multiple sclerosis, diagnosed by a neurologist in accordance with the 2010 McDonald criteria
Exclusion
- Concomitant parenchymal pulmonary disease or pleural disease
- Symptomatic cardiomyopathy
- Unable to perform pulmonary function testing or lung volume recruitment, due to comprehension or cooperation issues, physical inability such as bulbar or cerebellar dysfunction
- Contra-indication to pulmonary function testing or lung volume recruitment such as myocardial infarction, bleeding aortic aneurysm, intracranial hemorrhage within the previous month
- Known susceptibility to pneumothorax or pneumomediastinum
- Not competent to provide informed consent
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2017
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01891071
Start Date
July 1 2013
End Date
April 1 2017
Last Update
March 31 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6
2
Hôpital Charles-LeMoyne
Greenfield Park, Quebec, Canada, J4V2H1